[D-Arg2, Lys4]-Dermorphin (1-4) amide

The most selective µ-agonist reported to date. DALDA (YrFK-amide) should be useful not only as a research tool in basic opioid pharmacology but also for studying specifically peripheral µ-receptor interactions. Its very polar character should prevent DALDA from crossing the blood-brain barrier to any significant extent.